Financial Information of Renol Polychem Limited IPO
The Revenues from operations for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 6,256.23 Lakh, ₹ 652.31 Lakh and ₹ 4,185.74 Lakh. The EBITDA for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹ 740.59 Lakh, ₹ 230.05 Lakh and ₹ 137.21 Lakh. The Profit after Tax for the Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹ 499.68 Lakh, ₹ 153.39 Lakh and ₹ 72.81 Lakh respectively. This indicates a steady growth in financial performance.
Period Ended | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
---|---|---|---|
Reserve of Surplus | 784.20 | 320.30 | - |
Total Assets | 2,340.79 | 1,549.33 | 1,027.53 |
Total Borrowings | 695.47 | 257.91 | 535.65 |
Fixed Assets | 34.24 | 38.63 | 21.59 |
Cash | 296.68 | 101.37 | 12.08 |
Net Borrowing | 398.79 | 156.54 | 523.57 |
Revenue | 6,256.23 | 652.31 | 4,185.74 |
EBITDA | 740.59 | 230.05 | 137.21 |
PAT | 499.68 | 153.39 | 72.81 |
EPS | 9.1 | 2.79 | 0 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Copyright @2020 Design & Developed by Info Web Software